General information about company |
|||
|---|---|---|---|
| Scrip Code | 513121 | ||
| NSE Symbol | ORICONENT | ||
| MSEI Symbol | NOTLISTED | ||
| ISIN | INE730A01022 | ||
| Name of company | ORICON ENTERPRISES LIMITED | ||
| Type of company | Main Board | ||
| Class of security | Equity | ||
| Date of start of financial year | 01-Apr-2024 | ||
| Date of end of financial year | 31-Mar-2025 | ||
| Date of board meeting when results were approved | 28-May-2025 | ||
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 08-May-2025 | ||
| Description of presentation currency | INR (in Actuals) | ||
| Reporting Type | Quarterly | ||
| Reporting Quarter | Fourth quarter | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Whether results are audited or unaudited for the quarter ended | Audited | ||
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited | ||
| Segment Reporting | Multi segment | ||
| Description of single segment | |||
| Start date and time of board meeting | 28-May-2025 16:00:00 | ||
| End date and time of board meeting | 28-May-2025 18:30:00 | ||
| Whether cash flow statement is applicable on company | Yes | ||
| Type of cash flow statement | Cash Flow Indirect | ||
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion | ||
Financial Results Ind-AS |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 1 | Income | ||
| Revenue from operations | 475091000 | 1725984000 | |
| Other income | 120043000 | 494102000 | |
| Total income | 595134000 | 2220086000 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 197252000 | 546034000 |
| (b) | Purchases of stock-in-trade | 93443000 | 542053000 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | -20140000 | -1891000 |
| (d) | Employee benefit expense | 56282000 | 267108000 |
| (e) | Finance costs | 1005000 | 66852000 |
| (f) | Depreciation, depletion and amortisation expense | 14256000 | 85258000 |
| (f) | Other Expenses | ||
| 1 | Other Expenses | 139244000 | 466432000 |
| 2 | Stores & Spares Consumed | 87483000 | 193368000 |
| Total other expenses | 226727000 | 659800000 | |
| Total expenses | 568825000 | 2165214000 | |
| 3 | Total profit before exceptional items and tax | 26309000 | 54872000 |
| 4 | Exceptional items | -32877000 | -32877000 |
| 5 | Total profit before tax | -6568000 | 21995000 |
| 6 | Tax expense | ||
| 7 | Current tax | -19549000 | -4091000 |
| 8 | Deferred tax | 3094000 | -4481000 |
| 9 | Total tax expenses | -16455000 | -8572000 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0 | 0 |
| 11 | Net Profit Loss for the period from continuing operations | 9887000 | 30567000 |
| 12 | Profit (loss) from discontinued operations before tax | 22450000 | 1605447000 |
| 13 | Tax expense of discontinued operations | 28737000 | 236380000 |
| 14 | Net profit (loss) from discontinued operation after tax | -6287000 | 1369067000 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | -3668000 | -7475000 |
| 16 | Total profit (loss) for period | -68000 | 1392159000 |
| 17 | Other comprehensive income net of taxes | -305847000 | -543744000 |
| 18 | Total Comprehensive Income for the period | -305915000 | 848415000 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | -67000 | 1392159000 | |
| Total profit or loss, attributable to non-controlling interests | -2000 | -2000 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | -305914000 | 848415000 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | -2000 | -2000 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 314095000 | 314095000 | |
| Face value of equity share capital | 2 | 2 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | 10137614000 | |
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 0.04 | 0.15 | |
| Diluted earnings (loss) per share from continuing operations | 0.04 | 0.15 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | -0.04 | 8.72 | |
| Diluted earnings (loss) per share from discontinued operations | -0.04 | 8.72 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 0 | 8.87 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 0 | 8.87 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | ||
Remarks |
|
|---|---|
| Debt equity ratio | |
| Debt service coverage ratio | |
| Interest service coverage ratio | |
Statement of Asset and Liabilities |
|||
|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-Apr-2024 | ||
| Date of end of reporting period | 31-Mar-2025 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Assets | |||
| 1 | Non-current assets | ||
| Property, plant and equipment | 2535373000 | ||
| Capital work-in-progress | 178479000 | ||
| Investment property | 236676000 | ||
| Goodwill | 859511000 | ||
| Other intangible assets | 1573000 | ||
| Intangible assets under development | 0 | ||
| Biological assets other than bearer plants | 0 | ||
| Investments accounted for using equity method | 35309000 | ||
| Non-current financial assets | |||
| Non-current investments | 5271907000 | ||
| Trade receivables, non-current | 0 | ||
| Loans, non-current | 190908000 | ||
| Other non-current financial assets | 86957000 | ||
| Total non-current financial assets | 5549772000 | ||
| Deferred tax assets (net) | 24858000 | ||
| Other non-current assets | 149603000 | ||
| Total non-current assets | 9571154000 | ||
| 2 | Current assets | ||
| Inventories | 301634000 | ||
| Current financial asset | |||
| Current investments | 681315000 | ||
| Trade receivables, current | 441356000 | ||
| Cash and cash equivalents | 91827000 | ||
| Bank balance other than cash and cash equivalents | 310538000 | ||
| Loans, current | 869476000 | ||
| Other current financial assets | 480779000 | ||
| Total current financial assets | 2875291000 | ||
| Current tax assets (net) | 0 | ||
| Other current assets | 88868000 | ||
| Total current assets | 3265793000 | ||
| 3 | Non-current assets classified as held for sale | 539450000 | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0 | |
| Total assets | 13376397000 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 314149000 | ||
| Other equity | 12207929000 | ||
| Total equity attributable to owners of parent | 12522078000 | ||
| Non controlling interest | 70000 | ||
| Total equity | 12522148000 | ||
| 2 | Liabilities | ||
| Non-current liabilities | |||
| Non-current financial liabilities | |||
| Borrowings, non-current | 22362000 | ||
| Trade payables, non-current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0 | ||
| Total Trade payable | 0 | ||
| Other non-current financial liabilities | 14681000 | ||
| Total non-current financial liabilities | 37043000 | ||
| Provisions, non-current | 88464000 | ||
| Deferred tax liabilities (net) | 110459000 | ||
| Deferred government grants, Non-current | 0 | ||
| Other non-current liabilities | 8353000 | ||
| Total non-current liabilities | 244319000 | ||
| Current liabilities | |||
| Current financial liabilities | |||
| Borrowings, current | 67312000 | ||
| Trade payables, current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 7823000 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 316277000 | ||
| Total Trade payable | 324100000 | ||
| Other current financial liabilities | 121269000 | ||
| Total current financial liabilities | 512681000 | ||
| Other current liabilities | 28752000 | ||
| Provisions, current | 25134000 | ||
| Current tax liabilities (Net) | 5634000 | ||
| Deferred government grants, Current | 0 | ||
| Total current liabilities | 572201000 | ||
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 37729000 | |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0 | |
| Total liabilities | 854249000 | ||
| Total equity and liabilites | 13376397000 | ||
| Disclosure of notes on assets and liabilities | Textual Information(1) | ||
Text Block |
|||
|---|---|---|---|
| Textual Information(1) | Property Plant and Equipment includes Right to use assets amounting to Rupees 188.44 | ||
Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results |
|||||||
|---|---|---|---|---|---|---|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
| Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 | |||||
| Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 | |||||
| Whether accounts are audited or unaudited | Audited | Audited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Packaging - Continuing Operations | 400649000 | 1259131000 | ||||
| 2 | Trading | 96338000 | 542515000 | ||||
| 3 | Discontinued Operations | 187305000 | 2200320000 | ||||
| Total Segment Revenue | 684292000 | 4001966000 | |||||
| Less: Inter segment revenue | 21896000 | 21896000 | |||||
| Revenue from operations | 662396000 | 3926303000 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Packaging - Continuing Operations | 7050000 | 37876000 | ||||
| 2 | Trading | 1740000 | -63930000 | ||||
| 3 | Discontinued Operations | 22452000 | 1605449000 | ||||
| Total Profit before tax | 31242000 | 1579395000 | |||||
| i. Finance cost | 1005000 | 1005000 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | 18022000 | 18022000 | |||||
| Profit before tax | 12215000 | 1619968000 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Packaging - Continuing Operations | 1030110000 | 1030110000 | ||||
| 2 | Trading | 650813000 | 650813000 | ||||
| 3 | Discontinued Operations | 333531000 | 333531000 | ||||
| Total Segment Asset | 2014454000 | 2014454000 | |||||
| Un-allocable Assets | 11361943000 | 11361943000 | |||||
| Net Segment Asset | 13376397000 | 13376397000 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Packaging - Continuing Operations | 354963000 | 354963000 | ||||
| 2 | Trading | 105431000 | 105431000 | ||||
| 3 | Discontinued Operations | 37729000 | 37729000 | ||||
| Total Segment Liabilities | 498123000 | 498123000 | |||||
| Un-allocable Liabilities | 268191000 | 268191000 | |||||
| Net Segment Liabilities | 766314000 | 766314000 | |||||
| Disclosure of notes on segments | |||||||
Other Comprehensive Income |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement of Defined Benefit Plans | -11498000 | -5115000 |
| 2 | Equity Instruments through OCI | -334905000 | -666563000 |
| 3 | Change in revaluation Surplus - Freehold Land | 0 | 0 |
| 4 | Deferred tax on above | 45200000 | 64120000 |
| Total Amount of items that will not be reclassified to profit and loss | -301203000 | -607558000 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 0 | 0 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Exchange Differneces in translating to Financial Statement of a Foreign Operation | -986000 | 32064000 |
| 2 | Debt Instruments through OCI (Net of Tax) | -3658000 | 31750000 |
| Total Amount of items that will be reclassified to profit and loss | -4644000 | 63814000 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0 | 0 |
| 5 | Total Other comprehensive income | -305847000 | -543744000 |
Cash flow statement, indirect |
||||||
|---|---|---|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | |||||
| A | Date of start of reporting period | 01-Apr-2024 | ||||
| B | Date of end of reporting period | 31-Mar-2025 | ||||
| C | Whether results are audited or unaudited | Audited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Part I | Blue color marked fields are non-mandatory. | |||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 21995000 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 0 | |||||
| Adjustments for decrease (increase) in inventories | -221789000 | |||||
| Adjustments for decrease (increase) in trade receivables, current | -3129000 | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | -219805000 | |||||
| Adjustments for decrease (increase) in other current assets | 0 | |||||
| Adjustments for decrease (increase) in other non-current assets | 42557000 | |||||
| Adjustments for other financial assets, non-current | 0 | |||||
| Adjustments for other financial assets, current | 54431000 | |||||
| Adjustments for other bank balances | 0 | |||||
| Adjustments for increase (decrease) in trade payables, current | 66296000 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0 | |||||
| Adjustments for increase (decrease) in other current liabilities | 0 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0 | |||||
| Adjustments for depreciation and amortisation expense | -185951000 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0 | |||||
| Adjustments for provisions, current | 393000 | |||||
| Adjustments for provisions, non-current | 0 | |||||
| Adjustments for other financial liabilities, current | 210019000 | |||||
| Adjustments for other financial liabilities, non-current | 90281000 | |||||
| Adjustments for unrealised foreign exchange losses gains | 32063000 | |||||
| Adjustments for dividend income | -96656000 | |||||
| Adjustments for interest income | 0 | |||||
| Adjustments for share-based payments | 0 | |||||
| Adjustments for fair value losses (gains) | -124000 | |||||
| Adjustments for undistributed profits of associates | 0 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0 | |||||
| Other adjustments to reconcile profit (loss) | -299368000 | |||||
| Other adjustments for non-cash items | 0 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Total adjustments for reconcile profit (loss) | -337470000 | |||||
| Net cash flows from (used in) operations | -315475000 | |||||
| Dividends received | 33854000 | |||||
| Interest paid | 65999000 | |||||
| Interest received | 221076000 | |||||
| Income taxes paid (refund) | 269465000 | |||||
| Other inflows (outflows) of cash | 0 | |||||
| Net cash flows from (used in) operating activities | -396009000 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 4931411000 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0 | |||||
| Other cash receipts from sales of interests in joint ventures | 0 | |||||
| Other cash payments to acquire interests in joint ventures | 0 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Proceeds from sales of property, plant and equipment | 353238000 | |||||
| Purchase of property, plant and equipment | 0 | |||||
| Proceeds from sales of investment property | 0 | |||||
| Purchase of investment property | 2571901000 | |||||
| Proceeds from sales of intangible assets | 0 | |||||
| Purchase of intangible assets | 0 | |||||
| Proceeds from sales of intangible assets under development | 0 | |||||
| Purchase of intangible assets under development | 0 | |||||
| Proceeds from sales of goodwill | 0 | |||||
| Purchase of goodwill | 0 | |||||
| Proceeds from biological assets other than bearer plants | 0 | |||||
| Purchase of biological assets other than bearer plants | 0 | |||||
| Proceeds from government grants | 0 | |||||
| Proceeds from sales of other long-term assets | 0 | |||||
| Purchase of other long-term assets | 0 | |||||
| Cash advances and loans made to other parties | 634680000 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 33154000 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
| Dividends received | -212681000 | |||||
| Interest received | 33854000 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | -228427000 | |||||
| Net cash flows from (used in) investing activities | 1637660000 | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0 | |||||
| Payments from changes in ownership interests in subsidiaries | 0 | |||||
| Proceeds from issuing shares | 0 | |||||
| Proceeds from issuing other equity instruments | 0 | |||||
| Payments to acquire or redeem entity's shares | 0 | |||||
| Payments of other equity instruments | 0 | |||||
| Proceeds from exercise of stock options | 0 | |||||
| Proceeds from issuing debentures notes bonds etc | 0 | |||||
| Proceeds from borrowings | -853867000 | |||||
| Repayments of borrowings | 0 | |||||
| Payments of lease liabilities | 38241000 | |||||
| Dividends paid | 78488000 | |||||
| Interest paid | 84434000 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | 0 | |||||
| Net cash flows from (used in) financing activities | -1055030000 | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 186621000 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 0 | |||||
| Net increase (decrease) in cash and cash equivalents | 186621000 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | -138603000 | |||||
| Cash and cash equivalents cash flow statement at end of period | 48018000 | |||||
Details of Impact of Audit Qualification |
|
|---|---|
| Whether results are audited or unaudited | Audited |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | S G N & Co. | Yes | 30-Nov-2027 | ||
|---|---|---|---|---|---|